1. Home
  2. BGI vs BNGO Comparison

BGI vs BNGO Comparison

Compare BGI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birks Group Inc.

BGI

Birks Group Inc.

HOLD

Current Price

$0.92

Market Cap

22.7M

Sector

N/A

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.57

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGI
BNGO
Founded
1879
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.7M
24.3M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
BGI
BNGO
Price
$0.92
$1.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
39.8K
169.0K
Earning Date
12-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$136,846,182.00
$28,720,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.56
P/E Ratio
N/A
N/A
Revenue Growth
7.45
N/A
52 Week Low
$0.56
$1.45
52 Week High
$2.03
$22.80

Technical Indicators

Market Signals
Indicator
BGI
BNGO
Relative Strength Index (RSI) 29.70 45.88
Support Level $1.00 $1.47
Resistance Level $0.93 $1.63
Average True Range (ATR) 0.03 0.06
MACD -0.01 0.00
Stochastic Oscillator 6.25 40.91

Price Performance

Historical Comparison
BGI
BNGO

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: